Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review
Authors:
- 26 August 2010
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 18 (1) , 1-7
Abstract
Summary. Thrombocytopenia (TCP) is a haematological condition known to occur in chronically infected hepatitis C (HCV) patients and may interfere with diagnostic procedures, such as liver biopsy, because of risk of bleeding. It may also exclude patients from effective antiviral treatment. We conducted a systematic literature review of articles and conference abstracts, to assess the prevalence of TCP among those with HCV and to describe demographics, liver disease stage and treatment characteristics of these patients. Studies of individuals with confirmed chronic HCV infection were included in the review if the study had a clear definition of thrombocytopenia and a sample size of at least 50 subjects. The final selection included 27 studies (21 articles and six abstracts). The definitions of thrombocytopenia varied between studies and were based either on platelet counts, with threshold levels ranging between ≤100 × 109 and ≤180 × 109/L, or on criteria set in haematological guidelines. The prevalence of TCP ranged from 0.16% to 45.4% and more than half of the studies reported a TCP prevalence of 24% or more. Because of the different TCP definitions, heterogeneity in study design and insufficient data on study characteristics such as age, gender, HCV treatment rates and disease severity an overall summary estimate of TCP prevalence among patients with HCV was not feasible. However, the relatively large prevalence in the majority of the studies suggests that there may be a substantial number of HCV patients at risk of bleeding complications and reduced likelihood of successful HCV antiviral treatment.Keywords
This publication has 34 references indexed in Scilit:
- Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C TrialClinical Gastroenterology and Hepatology, 2010
- Infectious Causes of Chronic Immune ThrombocytopeniaHematology/Oncology Clinics of North America, 2009
- Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver diseaseAlimentary Pharmacology & Therapeutics, 2007
- Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with Chronic Hepatitis B and CDigestive Diseases and Sciences, 2007
- Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment optionsAlimentary Pharmacology & Therapeutics, 2006
- Peripheral blood count abnormalities among patients with hepatitis C in the United StatesHepatology, 2002
- Relevance of Moderate Isolated Thrombopenia as a Strong Predictive Marker of Cirrhosis in Patients With Chronic Hepatitis C VirusAmerican Journal of Gastroenterology, 2001
- Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCRJournal of Korean Medical Science, 1999
- Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of HematologyAnnals of Internal Medicine, 1997
- Thrombocytopenia associated with hepatitis C viral infectionJournal of Hepatology, 1996